Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA’s Temple Sees Sentinel As Important Tool For Confirming And Analyzing Drug Adverse Events
Jan 23 2012
•
By
Cathy Kelly
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Drug Safety
More from Pink Sheet